UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+7.72%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$4.73B
AUM Growth
+$538M
(+13%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
48.18%
Holding
712
New
102
Increased
142
Reduced
245
Closed
144
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$245M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 3 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$87.5M |
Top Sells
| 1 |
First Horizon
FHN
|
+$179M |
| 2 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$146M |
| 3 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$70.5M |
| 4 |
Tower Semiconductor
TSEM
|
+$46.1M |
| 5 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$45.3M |
Sector Composition
| 1 | Healthcare | 32.5% |
| 2 | Technology | 15.54% |
| 3 | Financials | 12.09% |
| 4 | Real Estate | 8.52% |
| 5 | Materials | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Freeport-McMoran
FCX
$67B
| $2.3M | 0.05% |
+57,393
| New | +$2.3M |
|
|
AGEN
252
Agenus
AGEN
$136M
| $2.26M | 0.05% |
70,704
+6,334
| +10% | +$203K |
|
|
BDN
253
Brandywine Realty Trust
BDN
$768M
| $2.26M | 0.05% |
+486,115
| New | +$2.26M |
|
254
Boston Scientific
BSX
$160B
| $2.24M | 0.05% |
41,392
-4,616
| -10% | -$250K |
|
255
Roku
ROKU
$14.6B
| $2.24M | 0.05% |
35,000
-35,000
| -50% | -$2.24M |
|
256
Keros Therapeutics
KROS
$628M
| $2.22M | 0.05% |
55,341
+9,857
| +22% | +$396K |
|
257
Avantor
AVTR
$8.95B
| $2.21M | 0.05% |
107,470
-6,863
| -6% | -$141K |
|
|
FNVT
258
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
| $2.2M | 0.05% |
207,992
-4,689
| -2% | -$49.7K |
|
259
Box
BOX
$4.8B
| $2.2M | 0.05% |
+75,000
| New | +$2.2M |
|
|
DNAD
260
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
| $2.19M | 0.05% |
211,253
-4,761
| -2% | -$49.3K |
|
|
CITE
261
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $2.18M | 0.05% |
203,921
-4,597
| -2% | -$49.1K |
|
|
MRTX
262
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.16M | 0.05% |
59,698
+12,448
| +26% | +$450K |
|
263
Mueller Water Products
MWA
$4.18B
| $2.13M | 0.05% |
+131,500
| New | +$2.13M |
|
264
Haleon
HLN
$43.6B
| $2.13M | 0.04% |
254,185
+12,523
| +5% | +$105K |
|
265
Arcus Biosciences
RCUS
$1.22B
| $2.12M | 0.04% |
104,412
-10,068
| -9% | -$204K |
|
|
SPEC
266
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
| $2.11M | 0.04% |
192,601
-6,292
| -3% | -$69K |
|
267
Vera Therapeutics
VERA
$1.58B
| $2.05M | 0.04% |
127,991
-95,477
| -43% | -$1.53M |
|
268
Iovance Biotherapeutics
IOVA
$861M
| $2.04M | 0.04% |
289,384
-18,828
| -6% | -$133K |
|
269
SPDR S&P Metals & Mining ETF
XME
$2.35B
| $2.03M | 0.04% |
+40,000
| New | +$2.03M |
|
270
Trip.com Group
TCOM
$47.7B
| $2.01M | 0.04% |
+57,500
| New | +$2.01M |
|
271
Phathom Pharmaceuticals
PHAT
$882M
| $2.01M | 0.04% |
140,280
+40,187
| +40% | +$575K |
|
272
AtriCure
ATRC
$1.79B
| $1.99M | 0.04% |
40,293
-867
| -2% | -$42.8K |
|
|
BCYC
273
Bicycle Therapeutics
BCYC
$485M
| $1.99M | 0.04% |
77,902
-2,817
| -3% | -$71.9K |
|
274
Immunic
IMUX
$81.6M
| $1.99M | 0.04% |
791,687
+105,555
| +15% | +$265K |
|
275
OrthoPediatrics
KIDS
$524M
| $1.98M | 0.04% |
45,219
-4,427
| -9% | -$194K |
|